KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $233,653 | +1.9% | 1,382 | +30.6% | 0.00% | – |
Q2 2023 | $229,370 | +102.7% | 1,058 | +69.8% | 0.00% | – |
Q1 2023 | $113,136 | +31.3% | 623 | +43.2% | 0.00% | – |
Q4 2022 | $86,162 | +30.5% | 435 | +47.5% | 0.00% | – |
Q3 2022 | $66,000 | +371.4% | 295 | +170.6% | 0.00% | – |
Q2 2022 | $14,000 | +16.7% | 109 | +13.5% | 0.00% | – |
Q1 2022 | $12,000 | -78.6% | 96 | -77.5% | 0.00% | – |
Q4 2021 | $56,000 | +409.1% | 427 | +364.1% | 0.00% | – |
Q3 2021 | $11,000 | 0.0% | 92 | -2.1% | 0.00% | – |
Q2 2021 | $11,000 | 0.0% | 94 | +5.6% | 0.00% | – |
Q1 2021 | $11,000 | +57.1% | 89 | +34.8% | 0.00% | – |
Q4 2020 | $7,000 | +40.0% | 66 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | -78.3% | 66 | -67.6% | 0.00% | – |
Q2 2020 | $23,000 | +228.6% | 204 | +140.0% | 0.00% | – |
Q1 2020 | $7,000 | – | 85 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |